Skip to Content

A biotechnology company based in Eden Prairie, MN, is using University of Minnesota research to help shorten the list of patients awaiting organ transplants.

“Using research pioneered at the University of Minnesota, Miromatrix CEO, Dr. Jeff Ross, and his team are developing a process to convert pig livers, kidneys, hearts and pancreases into fully-functioning human organs. The company hopes to test the transplants on pigs within the next two years, and begin human trials by 2020.”

See the full story in Minne Inno.

Unit: 
Office for Technology Commercialization